While a number of technical issues arose during the reporting period, solutions have been identified and successfully implemented to resolve all known challenges. Overall, the magnitude of accomplishments achieved during the reporting period present a positive outlook on the company’s ability to reach in a timely manner, its next critical milestone involving demonstrating our technology to the marketplace
. Does that mean demo in the next three days?
- Forums
- ASX - By Stock
- AKP
- Ann: Full Year Statutory Accounts
Ann: Full Year Statutory Accounts, page-12
-
- There are more pages in this discussion • 74 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AKP (ASX) to my watchlist
|
|||||
Last
$6.20 |
Change
0.000(0.00%) |
Mkt cap ! $181.1M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AKP (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online